Insider Transactions in Q4 2022 at Aytu Biopharma, Inc (AYTU)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2022
|
Gary Cantrell Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
40,000
-19.6%
|
-
|
|
Dec 21
2022
|
John Donofrio Jr. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
187,804
-92.48%
|
-
|
|
Dec 21
2022
|
Carl Dockery |
SELL
Sale (or disposition) back to the issuer
|
Direct |
40,000
-21.19%
|
-
|
|
Dec 20
2022
|
Joshua R. Disbrow Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
80,000
-6.49%
|
-
|
|
Dec 19
2022
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
100,000
+35.45%
|
$0
$0.24 P/Share
|
|
Dec 19
2022
|
Joshua R. Disbrow Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
112,371
+8.36%
|
$0
$0.22 P/Share
|
|
Nov 18
2022
|
Mark K Oki Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+32.14%
|
$0
$0.23 P/Share
|
|
Nov 18
2022
|
Joshua R. Disbrow Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
222,000
+16.55%
|
$0
$0.24 P/Share
|